Drug intelligence / Profile preview

Men-B-Bio

Development stage
Unknown
Lead developer
Immunobiological Technology Institute (Bio-Manguinhos), Oswaldo Cruz Foundation (Fiocruz)
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Men-B-Bio is an investigational meningococcal serogroup B vaccine developed by Bio-Manguinhos/Fiocruz in collaboration with Instituto Butantan and the Adolfo Lutz Institute in Brazil. The vaccine is composed of detergent-treated outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) derived from prevalent Brazilian strains of Neisseria meningitidis serogroup B. It is designed to elicit a protective antibody response against serogroup B surface antigens. Clinical evaluation has included a randomized Phase II/III trial in children aged 4–11 years to assess immunogenicity and safety compared to the Cuban vaccine VAMENGOC-BC.

Other names
Brazilian MenB vaccineMeningococcus B Brazilian vaccine
02

Targets

fHbp (Factor H-binding protein)NadA (Neisserial adhesin A)Neisseria meningitidis serogroup B outer membrane vesicle surface epitopesNHBA (Neisserial heparin-binding antigen)

Beyond the preview

Go deeper on Men-B-Bio.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Men-B-Bio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call